Clinical and Pathologic Remission of Pediatric Ulcerative Colitis with Serum-Derived Bovine Immunoglobulin Added to the Standard Treatment Regimen
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that is particularly troublesome for pediatric patients, as current therapeutic options consist of biologic agents and steroids which alter the immune response and have the harmful side effect of leaving the patient more susceptible to...
Main Authors: | Rachelle A. Soriano, Asuncion G. Ramos-Soriano |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2017-05-01
|
Series: | Case Reports in Gastroenterology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/475923 |
Similar Items
-
Ulcerative Colitis and Immunoglobulin G4
Published: (2014-01-01) -
Clinical features and surgical selection in colitis-associated colorectal cancer with ulcerative colitis
by: Ryuichi Kuwahara, et al.
Published: (2023-08-01) -
Pyoderma gangrenosum associated with ulcerative colitis and tuberculosis brain abscess successfully treated with intravenous immunoglobulin
by: G S Nayanathara, et al.
Published: (2024-01-01) -
Editorial: Recent advances and new biomarkers in ulcerative colitis
by: Tsvetelina Velikova, et al.
Published: (2023-05-01) -
Management and treatment of distal ulcerative colitis
by: Andrea Calafiore, et al.
Published: (2013-12-01)